GMP Dairy Limited has been informed by the New Zealand Ministry for Primary Industries (MPI) that it is the first to be registered by the Chinese government for the export of Infant Formula products to China. According to MPI, the company does not need to take any corrective action to meet the Chinese requirements. Based on the list of manufacturers published last night on the Chinese authorities’ website, GMP Dairy is one of the five infant formula manufacturers who have been registered. From 1st May 2014, non-registered foreign manufacturers of infant formula will not be allowed to export infant formula to China. CNCA’s list of Approved Companies
In March 2014 as part of the registration process, four officials from the Certification and Accreditation Administration of the Peoples Republic of China (CNCA) accompanied by officials from MPI visited selected New Zealand’s infant formula plants as part of the MPI systems audit.
GMP Dairy’s factory in Auckland was one of the factories audited. It holds HACCP and RMP quality systems registration; which are essential for dairy manufacturing in New Zealand. It also utilises Good Manufacturing Practices (GMP) standard for the manufacture of infant formula.
Pharmaceutical production standards for the production of infant formula products are utlised by GMP Dairy. This improvement in production standards reflects China’s increased standards for infant formula as indicated in Opinions on Further Strengthening the quality and safety of infant formula milk powder work issued by China’s State Council on 21 June 2013.
GMP Dairy has benefited from the knowledge and experience of its parent company, GMP Pharmaceuticals, which has over 20 years experience in pharmaceutical manufacturing in Australia and New Zealand. GMP Pharmaceuticals has three manufacturing plants specialising in complementary medicines and dairy supplements. Products produced in these plants are exported to over 30 countries.
